FIELD: genetic engineering, molecular biology, medicine, pharmacy. SUBSTANCE: polypeptide thrombopoietin (TPO) shows biological activity of specific stimulation or enhancement of platelets formation. Amino acid sequence of TPO is given in description as well as DNA encoding polypeptide TPO with amino acid sequence given in description. Polypeptide TPO is obtained by its expression in suitable host followed by its isolation. Pharmaceutical composition for treatment of platelet-associated disorders comprises effective amount of polypeptide TPO and acceptable carrier. Pharmaceutical composition is administrated to subject in effective amount for treatment of platelet-associated disorders, for example, thrombocytopenia. Immunization of animal with polypeptide TPO is carried out and antibodies raised against this polypeptide are isolated. Invention ensures to perform effective treatment of disorders associated with platelets. EFFECT: improved method of preparing and treatment. 34 cl, 34 dwg, 9 tbl
Title | Year | Author | Number |
---|---|---|---|
THROMBOPOIETIN | 1994 |
|
RU2245365C2 |
DEGRADED ANTIBODY AS TPO AGONIST | 2001 |
|
RU2287534C2 |
POLYNUCLEOTIDE SEQUENCE (VARIANTS), POLYPEPTIDE (VARIANTS), FUSED PROTEIN, PHARMACEUTICAL COMPOSITION, MONOCLONAL ANTIBODY, STRAIN OF HYBRID CULTURED CELLS | 1995 |
|
RU2143491C1 |
DERIVATIVES OF FACTOR OF LIPOGENESIS INHIBITION AND THEIR PRODUCING | 1993 |
|
RU2138554C1 |
METHODS AND PREPARATIONS FOR STIMULATING GROWTH AND DIFFERENTIATION OF MEGACARIOCYTES | 1995 |
|
RU2158603C2 |
ANTIBODY DIRECTED ON SIGLEC-15 PROTEIN, BOUND WITH OSTEOCLASTS | 2008 |
|
RU2475499C2 |
ANTIBODIES, CONTAINING THERAPEUTIC TPO/EPO MIMETIC PEPTIDES | 2010 |
|
RU2559526C2 |
NOVEL PROTEINS AND METHODS OF THEIR PREPARING | 1996 |
|
RU2194714C2 |
POLYPEPTIDE, METHOD OF PRODUCING (VARIANTS), DNA (VARIANTS), VECTOR (VARIANTS), CELL, POLYPEPTIDE USING, PHARMACEUTICAL COMPOSITION (VARIANTS) | 1993 |
|
RU2177480C2 |
Siglec-15 ANTIBODY | 2010 |
|
RU2539790C2 |
Authors
Dates
2002-12-10—Published
1995-02-14—Filed